CB
Claris Biotherapeutics, Inc.
SEC filingBiotechnology · Half Moon Bay, CA
Amount raised$55.7Msold at filing
Total offering$121.5M$65.7M still open
Investors in the raise14count reported to the SEC
FiledAug 12, 2026first sale Nov 25, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Brian BaumExecutive Officer
Meredith FisherDirector
Reza DanaDirector
Stephen BradyExecutive Officer, Director
Henry RathExecutive Officer
Kenneth HarrisonDirector
Matt HobsonDirector
Michael DybbsDirector
Maha RadhakrishnanDirector
Susan OrrExecutive Officer
Clarke AtwellExecutive Officer
Marc de GaridelDirector
Executive officers, directors and promoters as listed on the Form D.